Please assess the completion status of the following clinical trial:

Trial Title: Acupuncture for Urinary Incontinence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Urge or stress urinary incontinence at least twice a week on average for at least 3 months~Exclusion Criteria:~* History of previous acupuncture~* History of a neurologic problem such as Parkinson's disease or multiple sclerosis that could affect bladder function~* Current treatment with overactive bladder medications or medications that relax the bladder~* Urinary catheter~* Pregnancy~* Inability to empty the bladder effectively~* Inability to toilet independently~* Current treatment with steroid~* Interstitial cystitis~* Chronic pelvic pain~* Current treatment with warfarin

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Acupuncture (Type: EXPERIMENTAL): Subjects will 12 acupuncture treatments over 6 weeks; treatment sessions occur twice a week. A total of 12 acupuncture needles will be inserted bilaterally at two leg points and four back points. Needles are manually inserted through a standard guide tube contained within a fitted sheath and the basal ring secured to the skin by double-sided tape. The needles remain in place for 25 minutes and are manually stimulated twice during each treatment.
- Sham acupuncture (Type: SHAM_COMPARATOR): Subjects will receive 12 sham acupuncture treatments (delivered twice a week) over 6 weeks. The sham needle is blunted needle whose shaft telescopes into the handle when tapped. While the needle appears to have been inserted, it does not actually penetrate the skin. It is held in place by the same standard guide tube used in the true acupuncture group. The acupuncture points and duration of treatment are the same as for the true acupuncture group.

Based on this trial design, predict the completion outcome and termination type (if applicable).